UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 11,027	$ 9,411
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	489	452
Amortization	1,568	1,714
Provision for (recovery of) losses on accounts receivable	(2)	0
(Gain) loss on disposal of assets	0	5
Deferred income taxes	(281)	(351)
Stock-based compensation expense	99	62
Tax benefit attributable to exercise of stock options	25	37
Changes in operating assets and liabilities:
Accounts receivable - trade	(1,340)	(510)
Accrued interest and other receivables	(5)	(35)
Inventories	(301)	(222)
Prepaid expenses and other current assets	40	36
Accounts payable	201	316
Accrued expenses	803	228
Total adjustments	1,296	1,732
Net cash provided by operating activities	12,323	11,143
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(174)	(237)
Capital expenditures for intangible assets	0	(9)
Net cash provided by (used in) investing activities	(174)	(246)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	224	306
Payment of dividends	(1,969)	(1,954)
Net cash provided by (used in) financing activities	(1,745)	(1,648)
Effect of exchange rate changes on cash	738	(971)
Net increase in cash and cash equivalents	11,142	8,278
Cash at beginning of period	26,296	23,278
Cash at end of period	37,438	31,556
Cash paid during the period for income taxes	3,753	3,342
Cash paid during the period for interest	$ 0	$ 0